Internal Medicine Doctors in Mendham, NJ Accepting Medicare

8 Internal Medicine doctors found. Showing 1 - 8

Frantz Junior M. Pierre-louis, M.D Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9 Burnett Rd, Mendham, NJ 07945 Phone: 347-232-7297

Matthew Schaikewitz, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Tempe Wick Rd, Mendham, NJ 07945 Phone: 973-543-2288

Christie J Prestifilippo, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19 E Main St, Mendham, NJ 07945 Phone: 973-543-6505    Fax: 973-543-2967

Dr. Sandy A Furey Iii, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8 Horizon Dr, Mendham, NJ 07945 Phone: 973-543-4220

James Henry Wolf, M.D. Internal Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 19 E Main St, Mendham, NJ 07945 Phone: 973-543-6505    Fax: 973-543-2967

Daniel Robert Amoruso, M.D. Internal Medicine - Interventional Cardiology Medicare: Accepting Medicare Assignments Practice Location: 8 Tempe Wick Rd Ste 300, Mendham, NJ 07945 Phone: 973-543-2288

Allison Carthan Connolly, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 19 E Main St, Mendham, NJ 07945 Phone: 973-543-6599

Gregg Gerard Marella, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 19 E Main St, Mendham, NJ 07945 Phone: 973-543-6505    Fax: 973-543-2967

News Archive

Despite reduction in twin stillbirth rates, there is no change in still birth rates involving single fetus

A leading expert in fetal medicine at the University of Birmingham has warned that there is 'little room for complacency' over a fall in twin stillbirth rates as the reason for this phenomenon are complex.

Alzheimer's Society's response to Health Secretary Matt Hancock's cross-party social care announcement

Health and Social Care Secretary Matt Hancock has announced that the government will begin the process of cross party talks to find a long term solution to funding social care.

Asuragen, Life Technologies announce European launch of BCR/ABL1 Quant Test

Asuragen, Inc. and Life Technologies Corporation announced today that they have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant™ Test, Asuragen's clinically validated and cGMP manufactured test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML). Asuragen manufacturers the monitoring test, which is exclusively distributed by Life Technologies and runs on the company's Applied Biosystems CE-marked 7500 Fast Dx Real-Time PCR Instrument™.

Public-private partnership pilot program could facilitate drug development for neglected diseases

The National Center for Advancing Translational Science (NCATS) at the National Institutes of Health (NIH) announced a pilot program under which "three pharmaceutical companies have agreed to make dozens of their failed compounds available to researchers, who will investigate if the compounds can be re-purposed into successful treatments for other diseases," Ashley Bennett, senior policy associate at the Global Health Technologies Coalition (GHTC), writes in the group's "Breakthroughs" blog.

Read more Medical News

› Verified 4 days ago